BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 33705948)

  • 1. Current methodologies to refine bioavailability, delivery, and therapeutic efficacy of plant flavonoids in cancer treatment.
    Vazhappilly CG; Amararathna M; Cyril AC; Linger R; Matar R; Merheb M; Ramadan WS; Radhakrishnan R; Rupasinghe HPV
    J Nutr Biochem; 2021 Aug; 94():108623. PubMed ID: 33705948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flavonoids in cancer prevention.
    Park EJ; Pezzuto JM
    Anticancer Agents Med Chem; 2012 Oct; 12(8):836-51. PubMed ID: 22292763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivering flavonoids into solid tumors using nanotechnologies.
    Wang S; Zhang J; Chen M; Wang Y
    Expert Opin Drug Deliv; 2013 Oct; 10(10):1411-28. PubMed ID: 23862581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Research Progress in Flavonoids as Potential Anticancer Drug Including Synergy with Other Approaches.
    Hussain Y; Luqman S; Meena A
    Curr Top Med Chem; 2020; 20(20):1791-1809. PubMed ID: 32357817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flavonoids nanoparticles in cancer: Treatment, prevention and clinical prospects.
    Khan H; Ullah H; Martorell M; Valdes SE; Belwal T; Tejada S; Sureda A; Kamal MA
    Semin Cancer Biol; 2021 Feb; 69():200-211. PubMed ID: 31374244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the molecular targets of dietary flavonoid fisetin in cancer.
    Syed DN; Adhami VM; Khan N; Khan MI; Mukhtar H
    Semin Cancer Biol; 2016 Oct; 40-41():130-140. PubMed ID: 27163728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chrysin: Sources, beneficial pharmacological activities, and molecular mechanism of action.
    Mani R; Natesan V
    Phytochemistry; 2018 Jan; 145():187-196. PubMed ID: 29161583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanocrystal technology for improving therapeutic efficacy of flavonoids.
    Gujar K; Wairkar S
    Phytomedicine; 2020 Jun; 71():153240. PubMed ID: 32450461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement strategies for the oral bioavailability of poorly water-soluble flavonoids: An overview.
    Zhao J; Yang J; Xie Y
    Int J Pharm; 2019 Oct; 570():118642. PubMed ID: 31446024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nano-soldiers Ameliorate Silibinin Delivery: A Review Study.
    Ashrafizadeh M; Ahmadi Z; Mohammadinejad R; Farkhondeh T; Samarghandian S
    Curr Drug Deliv; 2020; 17(1):15-22. PubMed ID: 31721702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent discoveries of anticancer flavonoids.
    Raffa D; Maggio B; Raimondi MV; Plescia F; Daidone G
    Eur J Med Chem; 2017 Dec; 142():213-228. PubMed ID: 28793973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential role of naturally derived polyphenols and their nanotechnology delivery in cancer.
    Khushnud T; Mousa SA
    Mol Biotechnol; 2013 Sep; 55(1):78-86. PubMed ID: 23371307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition of flavonoids impacts their efficacy and safety.
    Ma Y; Zeng M; Sun R; Hu M
    Curr Drug Metab; 2014; 15(9):841-64. PubMed ID: 25658129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary flavonoids: bioavailability, metabolic effects, and safety.
    Ross JA; Kasum CM
    Annu Rev Nutr; 2002; 22():19-34. PubMed ID: 12055336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Potential of Flavonoids and Tannins from Medicinal Plants as Anticancer Agents.
    Teodor ED; Ungureanu O; Gatea F; Radu GL
    Anticancer Agents Med Chem; 2020; 20(18):2216-2227. PubMed ID: 32416704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flavonoid interactions during digestion, absorption, distribution and metabolism: a sequential structure-activity/property relationship-based approach in the study of bioavailability and bioactivity.
    Gonzales GB; Smagghe G; Grootaert C; Zotti M; Raes K; Van Camp J
    Drug Metab Rev; 2015 May; 47(2):175-90. PubMed ID: 25633078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flavonoid-mediated inhibition of intestinal ABC transporters may affect the oral bioavailability of drugs, food-borne toxic compounds and bioactive ingredients.
    Brand W; Schutte ME; Williamson G; van Zanden JJ; Cnubben NH; Groten JP; van Bladeren PJ; Rietjens IM
    Biomed Pharmacother; 2006 Nov; 60(9):508-19. PubMed ID: 16978825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel drug-phospholipid complex loaded micelle for baohuoside I enhanced oral absorption: in vivo and in vivo evaluations.
    Jin X; Zhang ZH; Sun E; Tan XB; Zhu FX; Jia XB
    Drug Dev Ind Pharm; 2013 Sep; 39(9):1421-30. PubMed ID: 23057574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flavonoids: prospective drug candidates.
    Cazarolli LH; Zanatta L; Alberton EH; Figueiredo MS; Folador P; Damazio RG; Pizzolatti MG; Silva FR
    Mini Rev Med Chem; 2008 Nov; 8(13):1429-40. PubMed ID: 18991758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flavonoids: A Myth or a Reality for Cancer Therapy?
    Forni C; Rossi M; Borromeo I; Feriotto G; Platamone G; Tabolacci C; Mischiati C; Beninati S
    Molecules; 2021 Jun; 26(12):. PubMed ID: 34208196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.